Long Covid banner

UKHSA Knowledge & Library Services have chosen Long COVID as one of the themes for Health Information Week 2022.

Online event

Long COVID: Vaccines, health inequalities, messaging and finding the evidence

Tuesday 5th July, 12:00-12:50

Long COVID: Vaccines, health inequalities, messaging and finding the evidence

This session featured speakers who shared their work on Long COVID. They spoke about their research and practice, and how they found, used and created high quality public health evidence:
• Rapid review on vaccines & Long COVID. Sean Harrison, Principal Evidence Reviewer, COVID-19 Rapid Evidence Service, UKHSA

• Using the HEAT tool to help local Long COVID services develop health inequalities plans. Rachael Gosling, Consultant in Public Health, NHS England & Improvement
• Devising the Long COVID search strategy to find the available evidence. Caroline de Brún, Knowledge & Evidence Specialist, UKHSA
Email us if you would like to request materials from the session.

 

Long COVID resources

Patient information

Your COVID Recovery provides general information on all aspects of recovering from COVID-19 including physical, emotional and psychological wellbeing, advice on recovery and information for families and carers.

Long-term effects of coronavirus (Long COVID) provides information and advice to the public about symptoms of Long COVID and how to manage them. NHS

Long Covid: a booklet for people who have signs and symptoms that continue or develop after acute Covid-19. SIGN/NICE/RCGP

How to manage post-viral fatigue after Covid-19. Royal College of Occupational Therapists

Long COVID: what support is available? Patient

How could long COVID impact your mental health? Patient

What is the latest advice on long COVID symptoms and treatment? Patient

What are the long-term health impacts of coronavirus? Patient

Long Covid: the symptoms and tips for recovery. British Heart Foundation

Living with long COVID. Age UK

Post COVID-19 fatigue, post/long COVID-19 syndromes and post-COVID ME/CFS. THE ME Association

 

Evidence reviews and briefings

The effectiveness of vaccination against long COVID: A rapid evidence briefing (15th February 2022) UKHSA COVID-19 Rapid Evidence Service

Epistemonikos post COVID-19 condition evidence list

WHO COVID-19 global literature on coronavirus disease: Long COVID

Characterising long COVID: a living systematic review
Michelen M, Manoharan L, Elkheir N, et al.
BMJ Global Health, 2021, 6(9):e005427. doi:10.1136/bmjgh-2021-005427 

COVID-19: a living systematic map of the evidence – long-COVID segment
EPPI-Centre
April 2022

A dynamic review of the evidence around ongoing Covid19 (often called Long Covid)
National Institute for Health and Care Research
March 2021

Long COVID through a public health lens: An umbrella review
Nittas V, Gao M, West EA, et al.
Public Health Reviews, 15 March 2022

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis HE, Assaf GS, McCorkell L, et al.
eClinicalMedicine, 2021, 38:101019

Post-COVID Conditions: CDC Science
Centres for Disease Control and Prevention
June 2022

An overview of post-COVID-19 condition (long COVID)
Canadian Journal of Health Technologies Horizon Scan, September 2021, 1(9)

 

Guidelines

COVID-19 rapid guideline: managing the long-term effects of COVID-19
NICE
November 2021

Long COVID: the NHS plan for 2021/22
NHS England and NHS Improvement
June 2021

National guidance for post-COVID syndrome assessment clinics
NHS England and NHS Improvement
April 2021

 

Clinical trials

International Clinical Trials Registry Platform – you can limit to COVID-19 searches and then type long-COVID in the search box, to view trials at different stages.

 

Networks

FutureNHS: Long COVID network (registration required with an NHS email)
This is a knowledge-sharing platform, where NHS professionals can share experiences with managing long-COVID, via a virtual forum. There are also links to resources and webinars.

Altea: A network for sharing evidence-based information on the long-term effects of COVID-19
Altea is a platform that connects people who are keen to understand the long-term consequences of contracting coronavirus disease (COVID-19), also known as long COVID or post COVID-19 condition, and to exchange expertise and experience.

CHAIN Network
CHAIN includes more than 75 sub-groups and special interest groups which enable members from different components of the network to focus on areas of common interest, including long-COVID.

 

Webinars

Expanding our understanding of Post COVID-19 condition
World Health Organization
February 2021

Expanding our understanding of post COVID-19 condition web series: Neurology and Mental Health
World Health Organization
March 2021

 

Research alert

The UKHSA Knowledge and Library Services has been producing a weekly Long-COVID Research Alert, each Wednesday morning since December 2021, and these are available on our Finding the Evidence: Coronavirus page, Keeping Up To Date tab, option 3.

 

Search strategies

The COVID-19 section of the search strategies below, were developed by the information scientists at NICE, and the rest of the terms have been amalgamated from a range of search strategies developed by UKHSA Knowledge and Library Services, and information scientists at World Health Organization and Centers for Disease Control and Prevention.

Embase Medline
1. exp severe acute respiratory syndrome coronavirus 2/ 1. exp SARS-CoV-2/
2. coronavirus disease 2019/ 2. exp COVID-19/
3. experimental coronavirus disease 2019/ 3. (corona* adj1 (virus* or viral*)).tw,kw,kf.
4. (corona* adj1 (virus* or viral*)).tw,kw. 4. (CoV not (Coefficien* or “co-efficien*” or covalent* or Covington* or covariant* or covarianc* or “cut-off value*” or “cutoff value*” or “cut-off volume*” or “cutoff volume*” or “combined optimi?ation value*” or “central vessel trunk*” or CoVR or CoVS)).tw,kw,kf.
5. (CoV not (Coefficien* or co-efficien* or covalent* or covington or covariant* or covarianc* or “cut-off value*” or “cutoff value*” or “cut-off volume*” or “cutoff volume*” or “combined optimi?ation value*” or “central vessel trunk” or CoVR or CoVS)).tw,kw. 5. (coronavirus* or 2019nCoV* or 19nCoV* or “2019 novel*” or Ncov* or “n-cov” or “SARS-CoV-2*” or “SARSCoV-2*” or SARSCoV2* or “SARS-CoV2*” or “severe acute respiratory syndrome*” or COVID*2).tw,kw,kf.
6. (coronavirus* or 2019nCoV* or 19nCoV* or “2019 novel*” or Ncov* or “n-cov” or “SARS CoV-2*” or “SARSCoV-2*” or SARSCoV2* or “SARS-CoV2*” or “severe acute respiratory syndrome*” or COVID*2).tw,kw. 6. or/1-5
7. or/1-6 7. limit 6 to yr=”2019-Current”
8. limit 7 to yr=”2019-Current” 8. (7 and english.lg.) not (letter or historical article or comment or editorial or news).pt. not (Animals/ not humans/)
9. (8 and english.lg.) not (letter or editorial).pt. not (nonhuman/ not human/) not (conference abstract or conference paper or conference proceeding or “conference review”).pt. 9. ((after or following or post) adj (“hospital discharge” or “patient discharge” or discharge or recovery or infection or ICU or “intensive care”)).ti,kw,kf.
10. exp long COVID/ 10. ((medium or long-term or expanded or extended or recurr* or sustain* or persist* or prolong* or continu* or debilitating or long-lasting or longitudinal) adj (effect* or symptom* or impact* or outcome* or recover* or suffer* or sequela* or profile* or complication*)).ti,kw,kf.
11. ((after or following or post) adj (“hospital discharge” or “patient discharge” or discharge or recovery or infection or ICU or “intensive care”)).ti,kw,kf. 11. ((post-viral or postviral or long or chronic or persistent or post-acute or lasting or post-infectio* or post covid* or residual or ongoing) adj (haul* or symptom* or syndrome* or fatigue or covid* or covid-19 or illness or condition*)).ti,kw,kf.
12. ((medium or long-term or expanded or extended or recurr* or sustain* or persist* or prolong* or continu* or debilitating or long-lasting or longitudinal) adj (effect* or symptom* or impact* or outcome* or recover* or suffer* or sequela* or profile* or complication*)).ti,kw,kf. 12. Long Term Adverse Effects/
13. ((post-viral or postviral or long or chronic or persistent or post-acute or lasting or post-infectio* or post covid* or residual or ongoing) adj (haul* or symptom* or syndrome* or fatigue or covid* or covid-19 or illness or condition*)).ti,kw,kf. 13. (post-acute sequelae of COVID-19 or PASC).tw,kw,kf.
14. Long Term Adverse Effects/ 14. (chronic COVID syndrome or CCS).tw,kw,kf.
15. (post-acute sequelae of COVID-19 or PASC).tw,kw,kf. 15. complication*.ti,kw,kf.
16. (chronic COVID syndrome or CCS).tw,kw,kf. 16. long.ti,kw,kf.
17. complication/ 17. or/9-16
18. long.ti,kw,kf. 18. 8 and 17
19. or/10-18 19. limit 18 to (english language and yr=”2019 -Current”)
20. 9 and 19
21. limit 20 to (english language and yr=”2019 -Current”)

 

Return to Health Information Week 2022 homepage.

Print Friendly, PDF & Email